The Stock Sniper, Founded by Iris Yuan, Launches a Free Webinar on Minimalist Trading for Professionals

2 days ago

Singapore, May 13, 2025 (GLOBE NEWSWIRE) -- The Stock Sniper, a financial education company founded by former corporate banker Iris…

Exterior Painting Services Help Castle Rock Homeowners Boost Home Value

2 days ago

Castle Rock, May 13, 2025 (GLOBE NEWSWIRE) -- Castle Rock, Colorado - Elk Horn Painting, trusted for its exceptional exterior…

Atlantic American Corporation Reports First Quarter Results for 2025

2 days ago

ATLANTA, May 13, 2025 (GLOBE NEWSWIRE) -- Atlantic American Corporation (Nasdaq- AAME) today reported net income of $0.8 million, or…

Steelworkers demand action from new cabinet on jobs, industry, trade and union rights

2 days ago

TORONTO, May 13, 2025 (GLOBE NEWSWIRE) -- As Canada’s new federal Cabinet is sworn in today, the United Steelworkers union…

Jeffersonville Bancorp Announces First Quarter Earnings of $2,718,000 or $0.64 per share; Declares Dividend of $0.15

2 days ago

JEFFERSONVILLE, N.Y., May 13, 2025 (GLOBE NEWSWIRE) -- Jeffersonville Bancorp, Inc. (OTCQB - JFBC) announced today first quarter net income…

Burgundy confirms polished sales strategy evolution; closes Perth Office

2 days ago

CALGARY, Alberta, May 13, 2025 (GLOBE NEWSWIRE) -- Burgundy Diamond Mines Limited (ASX:BDM) (Burgundy or the Company) confirms the strategic…

Four Egnyte Leaders Spotlighted on the 2025 Women of the Channel List

2 days ago

MOUNTAIN VIEW, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Egnyte, a leader in secure content collaboration, intelligence, and governance, proudly…

Metastatic Colorectal Cancer Clinical Trial Pipeline Accelerates as 150+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

2 days ago

Metastatic colorectal cancer (mCRC) continues to pose a clinical and commercial challenge, with low 5-year survival rates and limited durable…

Alumis Stockholders Approve Merger with ACELYRIN

2 days ago

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies…

ACELYRIN Stockholders Approve Merger with Alumis to Create Clinical Biopharma Company Dedicated to Innovating, Developing and Commercializing Transformative Therapies for Immune-mediated Diseases

2 days ago

LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, Inc. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating…

This website uses cookies.